Follow us for updates
© 2022
Read the Story →

Philippines Receives First Pfizer COVID Vaccines

High efficacy.
by Arianne Merez
May 10, 2021
Photo/s: Courtesy of WHO

The Philippines on Monday night received its initial shipment of the high efficacy COVID-19 vaccines developed by Pfizer and BioNTech.

A total of 193,050 doses of Pfizer vaccines, courtesy of the global COVAX facility, were received by authorities led by Cabinet Sec. Karlo Nograles and COVID-19 testing czar Vince Dizon.

Earlier, Health Sec. Francisco Duque III said the Pfizer vaccines would likely be distributed in Metro Manila and other urban hubs that could handle the jab's storage requirement.


Pfizer Vaccine Confirmed to Protect 95% in Largest Study Yet

Pfizer Says COVID Vaccine 100% Effective on 12-15 Year Olds

The vaccine, found to be 95% effective in the largest real-world study yet, was the first to receive emergency use authorization in the Philippines.

Pfizer jabs however were not immediately made available to the country which currently relies on China's Sinovac, AstraZeneca, and Russia's Sputnik V vaccines for its COVID-19 vaccination program.

Continue reading below ↓


WATCH: Why It Makes Sense to Get the COVID Vaccine Available to You

How COVID Vaccines Work and Why You Should Get One

How Soon Can a Recovered COVID Patient Get a Vaccine?

Reportr is now on Quento. Download the app on iOS and Android or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
With the reopening of several local destinations, this app has never been more timely.
The focus should be on the poor, incoming senator said.
GCash isn't just about paying bills and transferring funds.
You'll need a bigger wallet, incoming BSP gov says.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.